Figure 4: Treatment with the DNA demethylating agent 5-Aza-2’-deoxycytidine (5-AZA) and the histone de-acetylase inhibitor trichostatin A (TSA) derepresses BMP3 gene expression in (A) KMC-1 cells and (B) Mz-ChA-1 cells.